Anne W. Rimoin*, Neville Kisalu†, Benoit Kebela-Ilunga‡, Thibaut Mukaba†, Linda L. Wright§, Pierre Formenty¶, Nathan D. Wolfe#, Robert Loshima Shongo‡, Florimond Tshioko**, Emile Okitolonda††, Jean-Jacques Muyembe†, Robert W. Ryder‡‡, and Hermann Meyer§§
Author affiliations: *University of California, Los Angeles, California, USA; †National Institute of Biomedical Research, Kinshasa, Democratic Republic of Congo; ‡Ministry of Health, Kinshasa, Democratic Republic of Congo; §National Institutes of Health, Bethesda, Maryland, USA; ¶World Health Organization, Geneva, Switzerland; #Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA; **World Health Organization, Kinshasa, Democratic Republic of Congo; ††Kinshasa School of Public Health, Kinshasa, Democratic Republic of Congo; ‡‡University of North Carolina, Chapel Hill, North Carolina, USA; §§Bundeswehr Institute of Microbiology, Munich, Germany;
Main Article
Table 1
Orthopoxviruses and varicella-zoster virus, Democratic Republic of Congo, 2001–2004*
| Specimen (no. patients) |
MPX virus isolated |
PCR result
|
| Orthopoxvirus |
VZV |
| Crusts (50) |
16 |
18 |
21 |
| Vesicle fluid (51) |
19 |
21 |
24 |
| Crusts and vesicle fluid (35) |
8 and 5† |
13‡ |
17‡ |
| Total (136) |
48 |
52 |
62 |
Main Article
Top of Page